These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35752221)

  • 1. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy.
    Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
    Biochimie; 2022 Nov; 202():34-48. PubMed ID: 35752221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic actions of melatonin in cancer: possible mechanisms.
    Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
    Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basic mechanisms involved in the anti-cancer effects of melatonin.
    Mediavilla MD; Sanchez-Barcelo EJ; Tan DX; Manchester L; Reiter RJ
    Curr Med Chem; 2010; 17(36):4462-81. PubMed ID: 21062257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin: an endogenous miraculous indolamine, fights against cancer progression.
    Samanta S
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1893-1922. PubMed ID: 32583237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Action of melatonin on squamous cell carcinoma and other tumors of the oral cavity (Review).
    Cutando A; López-Valverde A; DE Vicente J; Gimenez JL; Carcía IA; DE Diego RG
    Oncol Lett; 2014 Apr; 7(4):923-926. PubMed ID: 24944644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatic activities of melatonin: Roles in cell cycle, apoptosis, and autophagy [Biochimie 200 (2022) 44-59].
    Targhazeh N; Reiter RJ; Rahimi M; Qujeq D; Yousefi T; Shahavi MH; Mir SM
    Biochimie; 2022 Sep; 200():44-59. PubMed ID: 35618158
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells.
    Cui P; Luo Z; Zhang H; Su Y; Li A; Li H; Zhang J; Yang Z; Xiu R
    J Pineal Res; 2006 Nov; 41(4):358-62. PubMed ID: 17014693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity of melatonin as an oncostatic agent.
    Panzer A; Viljoen M
    J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncostatic action of melatonin: facts and question marks.
    Pawlikowski M; Winczyk K; Karasek M
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():24-9. PubMed ID: 12019348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin: Nature's most versatile biological signal?
    Pandi-Perumal SR; Srinivasan V; Maestroni GJ; Cardinali DP; Poeggeler B; Hardeland R
    FEBS J; 2006 Jul; 273(13):2813-38. PubMed ID: 16817850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pain control by melatonin: Physiological and pharmacological effects.
    Chen WW; Zhang X; Huang WJ
    Exp Ther Med; 2016 Oct; 12(4):1963-1968. PubMed ID: 27698681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway.
    Mao L; Yuan L; Slakey LM; Jones FE; Burow ME; Hill SM
    Breast Cancer Res; 2010; 12(6):R107. PubMed ID: 21167057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin and mammary cancer: a short review.
    Sánchez-Barceló EJ; Cos S; Fernández R; Mediavilla MD
    Endocr Relat Cancer; 2003 Jun; 10(2):153-9. PubMed ID: 12790777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand.
    Wiesenberg I; Missbach M; Kahlen JP; Schräder M; Carlberg C
    Nucleic Acids Res; 1995 Feb; 23(3):327-33. PubMed ID: 7885826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
    Blask DE; Sauer LA; Dauchy RT
    Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Oncostatic Effects of Melatonin against Prostate Cancer.
    Samanta S
    Crit Rev Oncog; 2021; 26(3):53-67. PubMed ID: 35377986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells.
    Marelli MM; Limonta P; Maggi R; Motta M; Moretti RM
    Prostate; 2000 Nov; 45(3):238-44. PubMed ID: 11074526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin membrane receptors in peripheral tissues: distribution and functions.
    Slominski RM; Reiter RJ; Schlabritz-Loutsevitch N; Ostrom RS; Slominski AT
    Mol Cell Endocrinol; 2012 Apr; 351(2):152-66. PubMed ID: 22245784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship.
    Carlberg C; Wiesenberg I
    J Pineal Res; 1995 May; 18(4):171-8. PubMed ID: 8531047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonin and its ubiquitous anticancer effects.
    Bhattacharya S; Patel KK; Dehari D; Agrawal AK; Singh S
    Mol Cell Biochem; 2019 Dec; 462(1-2):133-155. PubMed ID: 31451998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.